Parkinsonism Identified as Potential Side Effect of Immune Checkpoint Inhibitors
Release Date: 11/18/2026
Neurology Minute
Dr. Halley Alexander discusses the Neurology Today article, "Parkinsonism Identified as Potential Side Effect of Immune Checkpoint Inhibitors" by Stacey Burling, available in the November 5th issue of or at . Help shape the future of the Neurology Minute® Daily Briefing. ! Show citation: Birzu C, Bihan K, et al. Parkinsonism as a Potential Neurologic Immune-Mediated Adverse Event of Immune Checkpoint Inhibitors. Neurol Neuroimmunol Neuroinflamm. 2026 Sep;13(5):e200644. doi:
info_outlineNeurology Minute
In the final episode of this series, Dr. Stacey Clardy and Dr. Justin Abbatemarco discuss considerations for timing vaccinations in patients who are preparing to start or are already receiving anti-CD20 therapy. Help shape the future of the Neurology Minute® Daily Briefing. ! Show citation: Abbatemarco JR, Begum F, Villalba JA, et al. Establishing Potosi Virus as a Human Pathogen: Fatal Neuroinvasive Disease in a B-Cell-Depleted Patient. Neurology. 2026;107(10):e218683. doi:
info_outlineNeurology Minute
In the November episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost explore how new therapies, diagnostic tools, and emerging technologies are shaping the future of neurology. Stay informed by watching the . Help shape the future of the Neurology Minute® Daily Briefing. !
info_outlineNeurology Minute
In part three of this series, Dr. Stacey Clardy and Dr. Justin Abbatemarco discuss practical advice for people receiving anti-CD20 therapy to reduce their exposure to mosquitoes and ticks. Show citation: Abbatemarco JR, Begum F, Villalba JA, et al. Establishing Potosi Virus as a Human Pathogen: Fatal Neuroinvasive Disease in a B-Cell-Depleted Patient. Neurology. 2026;107(10):e218683. doi:
info_outlineNeurology Minute
In part two of this series, Dr. Stacey Clardy and Dr. Justin Abbatemarco discuss the household exposures clinicians should consider when a patient receiving B-cell therapy develops fever, confusion, or new difficulty walking. Show citation: Abbatemarco JR, Begum F, Villalba JA, et al. Establishing Potosi Virus as a Human Pathogen: Fatal Neuroinvasive Disease in a B-Cell-Depleted Patient. Neurology. 2026;107(10):e218683. doi:
info_outlineNeurology Minute
In part one of this series, Dr. Stacey Clardy and Dr. Justin Abbatemarco discuss why a nearly normal spinal fluid profile or a negative antibody test can be misleading when evaluating a patient receiving anti-CD20 therapy for possible encephalitis or another viral infection.
info_outlineNeurology Minute
In the second episode of this series, Dr. Derek Stitt discusses Glossopharyngeal neuralgia and nervus intermedius neuralgia, two types of cranial neuralgia.
info_outlineNeurology Minute
In part one of this series, Dr. Derek Stitt discusses trigeminal neuralgia and, more specifically, how to make sure that's actually the diagnosis.
info_outlineNeurology Minute
In this episode, Dr. Jose Posas reviews the Capitol Hill Report from October 26th, discussing international medical graduates, the Conrad 30 program, and the AAN’s efforts to strengthen visa pathways for physicians serving communities across the US. Stay updated with what’s happening on the hill by visiting . Learn how you can get involved with .
info_outlineNeurology Minute
In part two of this series, Dr. Dara Albert and Isaac Thorman discuss guidance for parents weighing whether to let their children play tackle football. Show citation: Thorman IB, Feldstein E, Sacknovitz A, et al. Youth Football and the Epidemic of Pediatric Brain Injury: Neurologic and Psychiatric Outcomes in a Cohort of 72,025 Concussions. Neurol Clin Pract. 2026;16(6):e200656. doi:
info_outlineDr. Halley Alexander discusses the Neurology Today article, "Parkinsonism Identified as Potential Side Effect of Immune Checkpoint Inhibitors" by Stacey Burling, available in the November 5th issue of Neurology Today or at neurologytoday.com.
Help shape the future of the Neurology Minute® Daily Briefing. Take our listener survey today!
Show citation:
Birzu C, Bihan K, et al. Parkinsonism as a Potential Neurologic Immune-Mediated Adverse Event of Immune Checkpoint Inhibitors. Neurol Neuroimmunol Neuroinflamm. 2026 Sep;13(5):e200644. doi: 10.1212/NXI.0000000000200644